United States High Content Screening Market Report to 2021

Publisher Name :
Date: 13-Oct-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of High Content Screening

Revenue, means the sales value of High Content Screening

This report studies sales (consumption) of High Content Screening in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Thermo Fisher Scientific (U.S.)

- Molecular Devices (U.S.)

- Perkin Elmer (U.S.)

- GE Healthcare Lifesciences (U.K

- ?Merck Millipore (Germany)

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- High Content Screening Instruments

- High Content Screening Consumables

- Microplates

- Other Consumables

- High Content Screening Software

- High Content Screening Services

Split by applications, this report focuses on sales, market share and growth rate of High Content Screening in each application, can be divided into

- Primary and Secondary Screening

- Target Identification and Validation

- Toxicity Studies

- Compound Profiling

- Other Applications

United States High Content Screening Market Report to 2021

Table of Contents
United States High Content Screening Market Report 2016
1 High Content Screening Overview
1.1 Product Overview and Scope of High Content Screening
1.2 Classification of High Content Screening
1.2.1 High Content Screening Instruments
1.2.2 High Content Screening Consumables
1.2.3 Microplates
1.2.4 Other Consumables
1.2.5 High Content Screening Software
1.2.6 High Content Screening Services
1.3 Application of High Content Screening
1.3.1 Primary and Secondary Screening
1.3.2 Target Identification and Validation
1.3.3 Toxicity Studies
1.3.4 Compound Profiling
1.3.5 Other Applications
1.4 United States Market Size Sales (Value) and Revenue (Volume) of High Content Screening (2011-2021)
1.4.1 United States High Content Screening Sales and Growth Rate (2011-2021)
1.4.2 United States High Content Screening Revenue and Growth Rate (2011-2021)
2 United States High Content Screening Competition by Manufacturers
2.1 United States High Content Screening Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States High Content Screening Revenue and Share by Manufactures (2015 and 2016)
2.3 United States High Content Screening Average Price by Manufactures (2015 and 2016)
2.4 High Content Screening Market Competitive Situation and Trends
2.4.1 High Content Screening Market Concentration Rate
2.4.2 High Content Screening Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States High Content Screening Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States High Content Screening Sales and Market Share by Type (2011-2016)
3.2 United States High Content Screening Revenue and Market Share by Type (2011-2016)
3.3 United States High Content Screening Price by Type (2011-2016)
3.4 United States High Content Screening Sales Growth Rate by Type (2011-2016)
4 United States High Content Screening Sales (Volume) by Application (2011-2016)
4.1 United States High Content Screening Sales and Market Share by Application (2011-2016)
4.2 United States High Content Screening Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States High Content Screening Manufacturers Profiles/Analysis
5.1 Thermo Fisher Scientific (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 High Content Screening Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Thermo Fisher Scientific (U.S.) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Molecular Devices (U.S.)
5.2.2 High Content Screening Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Molecular Devices (U.S.) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Perkin Elmer (U.S.)
5.3.2 High Content Screening Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Perkin Elmer (U.S.) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 GE Healthcare Lifesciences (U.K
5.4.2 High Content Screening Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 GE Healthcare Lifesciences (U.K High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 ?Merck Millipore (Germany)
5.5.2 High Content Screening Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 ?Merck Millipore (Germany) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
6 High Content Screening Manufacturing Cost Analysis
6.1 High Content Screening Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of High Content Screening
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 High Content Screening Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of High Content Screening Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States High Content Screening Market Forecast (2016-2021)
10.1 United States High Content Screening Sales, Revenue Forecast (2016-2021)
10.2 United States High Content Screening Sales Forecast by Type (2016-2021)
10.3 United States High Content Screening Sales Forecast by Application (2016-2021)
10.4 High Content Screening Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of High Content Screening
Table Classification of High Content Screening
Figure United States Sales Market Share of High Content Screening by Type in 2015
Figure High Content Screening Instruments Picture
Figure High Content Screening Consumables Picture
Figure Microplates Picture
Figure Other Consumables Picture
Figure High Content Screening Software Picture
Figure High Content Screening Services Picture
Table Application of High Content Screening
Figure United States Sales Market Share of High Content Screening by Application in 2015
Figure Primary and Secondary Screening Examples
Figure Target Identification and Validation Examples
Figure Toxicity Studies Examples
Figure Compound Profiling Examples
Figure Other Applications Examples
Figure United States High Content Screening Sales and Growth Rate (2011-2021)
Figure United States High Content Screening Revenue and Growth Rate (2011-2021)
Table United States High Content Screening Sales of Key Manufacturers (2015 and 2016)
Table United States High Content Screening Sales Share by Manufacturers (2015 and 2016)
Figure 2015 High Content Screening Sales Share by Manufacturers
Figure 2016 High Content Screening Sales Share by Manufacturers
Table United States High Content Screening Revenue by Manufacturers (2015 and 2016)
Table United States High Content Screening Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States High Content Screening Revenue Share by Manufacturers
Table 2016 United States High Content Screening Revenue Share by Manufacturers
Table United States Market High Content Screening Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market High Content Screening Average Price of Key Manufacturers in 2015
Figure High Content Screening Market Share of Top 3 Manufacturers
Figure High Content Screening Market Share of Top 5 Manufacturers
Table United States High Content Screening Sales by Type (2011-2016)
Table United States High Content Screening Sales Share by Type (2011-2016)
Figure United States High Content Screening Sales Market Share by Type in 2015
Table United States High Content Screening Revenue and Market Share by Type (2011-2016)
Table United States High Content Screening Revenue Share by Type (2011-2016)
Figure Revenue Market Share of High Content Screening by Type (2011-2016)
Table United States High Content Screening Price by Type (2011-2016)
Figure United States High Content Screening Sales Growth Rate by Type (2011-2016)
Table United States High Content Screening Sales by Application (2011-2016)
Table United States High Content Screening Sales Market Share by Application (2011-2016)
Figure United States High Content Screening Sales Market Share by Application in 2015
Table United States High Content Screening Sales Growth Rate by Application (2011-2016)
Figure United States High Content Screening Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific (U.S.) Basic Information List
Table Thermo Fisher Scientific (U.S.) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific (U.S.) High Content Screening Sales Market Share (2011-2016)
Table Molecular Devices (U.S.) Basic Information List
Table Molecular Devices (U.S.) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Molecular Devices (U.S.) High Content Screening Sales Market Share (2011-2016)
Table Perkin Elmer (U.S.) Basic Information List
Table Perkin Elmer (U.S.) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table Perkin Elmer (U.S.) High Content Screening Sales Market Share (2011-2016)
Table GE Healthcare Lifesciences (U.K Basic Information List
Table GE Healthcare Lifesciences (U.K High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table GE Healthcare Lifesciences (U.K High Content Screening Sales Market Share (2011-2016)
Table ?Merck Millipore (Germany) Basic Information List
Table ?Merck Millipore (Germany) High Content Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Table ?Merck Millipore (Germany) High Content Screening Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Content Screening
Figure Manufacturing Process Analysis of High Content Screening
Figure High Content Screening Industrial Chain Analysis
Table Raw Materials Sources of High Content Screening Major Manufacturers in 2015
Table Major Buyers of High Content Screening
Table Distributors/Traders List
Figure United States High Content Screening Production and Growth Rate Forecast (2016-2021)
Figure United States High Content Screening Revenue and Growth Rate Forecast (2016-2021)
Table United States High Content Screening Production Forecast by Type (2016-2021)
Table United States High Content Screening Consumption Forecast by Application (2016-2021)
  • Pain Drug Development Pipeline Review, 2017
    Published: 01-Jul-2017        Price: US 3995 Onwards        Pages: 229
    Summary This report provides an overview of the pain pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Osteoarthritis Pain, Migraine pain and Neuropathic Pain, therefore covering a number of the most difficult-to-treat chronic and acute pain subtypes. Osteoarthritis pain is the most common symptom associated with osteoarthritis which causes disruption ......
  • Skeletal Disease Drug Development Pipeline Review, 2017
    Published: 01-Jul-2017        Price: US 3995 Onwards        Pages: 176
    Summary This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for osteoporosis, post-menopausal osteoporosis and osteoarthritis (OA). OA is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. There are a total of 116 products in development for this in......
  • Transplantation Drug Development Pipeline Review, 2017
    Published: 01-Jul-2017        Price: US 3995 Onwards        Pages: 242
    Summary This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for graft-versus-host disease (GVHD), and the rejection of bone, liver, kidney, lung and heart transplants. Bone marrow transplant rejection is......
  • Global and Chinese Drug Discovery Industry, 2017 Market Research Report
    Published: 03-Jun-2017        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Drug Discovery Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Drug Discovery industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Discovery manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definitio......
  • High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022
    Published: 13-Apr-2017        Price: US 5650 Onwards        Pages: 166
    The global high-content screening (HCS) market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period. The factors expected to drive the growth of the market are cost containment in pharmaceutical R&D, increasing funding for cellular research, and technological advancements in HCS solutions during the forecast period. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. ......
  • Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017
    Published: 01-Apr-2017        Price: US 2995 Onwards        Pages: 1000
    Summary The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies The Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 report provides a detailed understanding and analysis of how, why and what terms companies enter prec......
  • Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2017
    Published: 01-Apr-2017        Price: US 2995 Onwards        Pages: 1000
    Summary The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 report. The report provides a detailed understanding and analysis of how, why and on what terms compani......
  • Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017
    Published: 01-Apr-2017        Price: US 2995 Onwards        Pages: 1000
    Summary The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the worlds leading biopharma companies The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2017 report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals and provides d......
  • Global High-Throughput Screening Market Research Report 2016
    Published: 04-Jan-2017        Price: US 2900 Onwards        Pages: 109
    Notes: Production, means the output of High-Throughput Screening Revenue, means the sales value of High-Throughput Screening This report studies High-Throughput Screening in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Agilent Technologies, Inc. (U.S.) - Danaher Corporation (U.S.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs